AMIT KHURANA from India, HAS BEEN INVITED TO PARTICIPATE IN THE PRESTIGIOUS LINDAU NOBEL LAUREATE MEETING.
AMIT is conducting research on the molecular mechanisms of chronic inflammatory liver diseases at the Medical Cell BioPhysics - Translational Liver Research (MCBP-TLR) department. During the event, he will have the opportunity to connect with Nobel laureates and other renowned scientists and gain new insights that could be invaluable for his research.
Dreaming of a Nobel Prize
At age seven, Amit lost his left eye due to a trauma, which changed his life in a positive way. Since eighth grade, he was fascinated by scientists such as J.J. Thomson, Marie Curie, and Niels Bohr, and dreamed of discovering a new element called Khuranium. Later, he discovered his love for science at the intersection of biology and chemistry, so he pursued a degree in Pharmacy at the University of Delhi. His passion for science was inspired by the discovery of the artificial gene by Nobel laureate late Prof. Hargobind Khorana. During lectures, Amit would get goosebumps hearing his name, as they share the same last name! Like any other passionate scientist, winning a Nobel Prize has always been Amit's dream.
When asked how this meeting will influence his research and career, he replied: "I believe that the Lindau meeting will be a springboard for my research and career, as I look forward to learning from the experiences of Nobel laureates and incorporating some of their virtues for curiosity and research in me. The meeting will open up a new professional network and will be of great value for the development of my career."
Current research
Amit is currently conducting research on the molecular mechanisms of non-alcoholic steatohepatitis (NASH), the most aggressive form of non-alcoholic fatty liver disease (NAFLD) that can lead to liver failure and cancer. Currently, there is no clinically approved treatment for NASH. He is investigating the role of the enzyme lipoxygenase (LOX) and testing a library of 14 new LOX inhibitors on their effect on NASH in vitro and in vivo models. Preliminary results are promising and suggest a potential therapy for NASH.
He is looking forward to meeting Professor Emmanuelle Charpentier during the meeting and learning more about the background of the discovery of the CRISPR-Cas9 system, a revolutionary technology promising for gene editing and gene therapy. "I am interested in the applications of CRISPR-Cas9 technology for the treatment of chronic inflammatory liver diseases and other diseases. I hope to meet Professor Charpentier and hear about her discovery of the CRISPR-Cas9 system and its implications for the future of medicine."
Lindau Nobel Laureate Meeting
The Lindau Nobel Laureate Meeting is an annual gathering of Nobel laureates and promising young scientists from around the world. It provides a unique opportunity for young scientists to connect with the foremost experts in their field and gain new insights that could help them in their careers.
